Matches in SemOpenAlex for { <https://semopenalex.org/work/W1971806877> ?p ?o ?g. }
Showing items 1 to 53 of
53
with 100 items per page.
- W1971806877 abstract "The antihypertensive efficacy and safety of the new long-acting selective alpha 1 inhibitor doxazosin were assessed in patients seen in clinical practice. A total of 232 mild to moderate hypertensive patients were treated by 35 physicians. After an initial 2-week period (phase 1) during which eligibility to enter the study was determined (diastolic blood pressure [BP] of 95 to 114 mm Hg), all patients received doxazosin 1 to 8 mg once daily for 8 weeks (phase 2). Patients were then maintained for another 4 weeks on the dosage necessary to control diastolic BP to less than or equal to 90 mm Hg (phase 3). Efficacy and toleration of doxazosin therapy during the study period were good; 81% of evaluable patients (n = 180) achieved BP control with a once-daily mean dosage of 3.3 mg. At the end of phase 2 BPs were reduced by (systolic/diastolic) 23.8/17.3 (sitting) and 23.7/17.1 mm Hg (standing). Side effects were generally mild to moderate and either were tolerated or disappeared with continued therapy; 7 patients withdrew from the study because of intolerable side effects. Overall results demonstrated that doxazosin is suitable for treatment of mild to moderate hypertension and can be administered on a once-daily basis, which enhances compliance." @default.
- W1971806877 created "2016-06-24" @default.
- W1971806877 creator A5035856860 @default.
- W1971806877 date "1987-05-01" @default.
- W1971806877 modified "2023-09-27" @default.
- W1971806877 title "A multicenter trial of doxazosin in West Germany" @default.
- W1971806877 cites W2013627905 @default.
- W1971806877 cites W2030970399 @default.
- W1971806877 cites W2049460546 @default.
- W1971806877 cites W2088479341 @default.
- W1971806877 cites W2093255760 @default.
- W1971806877 doi "https://doi.org/10.1016/0002-9149(87)90156-1" @default.
- W1971806877 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2884852" @default.
- W1971806877 hasPublicationYear "1987" @default.
- W1971806877 type Work @default.
- W1971806877 sameAs 1971806877 @default.
- W1971806877 citedByCount "18" @default.
- W1971806877 crossrefType "journal-article" @default.
- W1971806877 hasAuthorship W1971806877A5035856860 @default.
- W1971806877 hasConcept C126322002 @default.
- W1971806877 hasConcept C142724271 @default.
- W1971806877 hasConcept C2776370487 @default.
- W1971806877 hasConcept C2777590997 @default.
- W1971806877 hasConcept C535046627 @default.
- W1971806877 hasConcept C57900726 @default.
- W1971806877 hasConcept C71924100 @default.
- W1971806877 hasConcept C84393581 @default.
- W1971806877 hasConceptScore W1971806877C126322002 @default.
- W1971806877 hasConceptScore W1971806877C142724271 @default.
- W1971806877 hasConceptScore W1971806877C2776370487 @default.
- W1971806877 hasConceptScore W1971806877C2777590997 @default.
- W1971806877 hasConceptScore W1971806877C535046627 @default.
- W1971806877 hasConceptScore W1971806877C57900726 @default.
- W1971806877 hasConceptScore W1971806877C71924100 @default.
- W1971806877 hasConceptScore W1971806877C84393581 @default.
- W1971806877 hasLocation W19718068771 @default.
- W1971806877 hasLocation W19718068772 @default.
- W1971806877 hasOpenAccess W1971806877 @default.
- W1971806877 hasPrimaryLocation W19718068771 @default.
- W1971806877 hasRelatedWork W1970736097 @default.
- W1971806877 hasRelatedWork W1991955619 @default.
- W1971806877 hasRelatedWork W2012080558 @default.
- W1971806877 hasRelatedWork W2021922903 @default.
- W1971806877 hasRelatedWork W2135908330 @default.
- W1971806877 hasRelatedWork W2170385340 @default.
- W1971806877 hasRelatedWork W2374333696 @default.
- W1971806877 hasRelatedWork W2409458724 @default.
- W1971806877 hasRelatedWork W2471646660 @default.
- W1971806877 hasRelatedWork W3209443053 @default.
- W1971806877 isParatext "false" @default.
- W1971806877 isRetracted "false" @default.
- W1971806877 magId "1971806877" @default.
- W1971806877 workType "article" @default.